Clinical Trial Update: Efficacy of Cannabinoids in Amyotrophic Lateral Sclerosis or Motor Neurone Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial updating the efficacy of cannabinoids in amyotrophic lateral sclerosis (ALS) / motor neuron disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Motor Neuron Disease

Snippet

Sponsor: Gold Coast Hospital and Health Service | Conditions: Amyotrophic Lateral Sclerosis, Motor Neuron Disease | Phase 3 | Status: UNKNOWN